A detailed history of Quest Partners LLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 3,434 shares of DYN stock, worth $101,955. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,434
Previous 344 898.26%
Holding current value
$101,955
Previous $12.1 Million 916.05%
% of portfolio
0.01%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$31.94 - $47.04 $98,694 - $145,353
3,090 Added 898.26%
3,434 $123 Million
Q2 2024

Aug 06, 2024

BUY
$23.65 - $35.63 $4,233 - $6,377
179 Added 108.48%
344 $12.1 Million
Q1 2024

May 09, 2024

SELL
$13.06 - $29.18 $15,894 - $35,512
-1,217 Reduced 88.06%
165 $4.68 Million
Q4 2023

Feb 09, 2024

BUY
$6.62 - $13.64 $9,148 - $18,850
1,382 New
1,382 $18.4 Million

Others Institutions Holding DYN

About Dyne Therapeutics, Inc.


  • Ticker DYN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,765,400
  • Market Cap $1.54B
  • Description
  • Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...
More about DYN
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.